Rheumatology Medical News about Churg-Strauss syndrome

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Churg-Strauss syndrome successfully treated with rituximab
Rheumatology International, 10/15/09

Donvik KK et al. – Churg–Strauss syndrome (CSS) is characterized by small–vessel vasculitis, extravascular granulomatous inflammation, and massive eosinophilia in tissues and blood, and is often accompanied by a history of preclinical asthma and/or allergic rhinitis lasting several years before the syndrome develops its full clinical picture. The authors describe two patients resistant to conventional therapy who were treated with rituximab and experienced a rapid and substantial decrease in disease activity and asthmatic symptoms and an increase in physical capacity.

<< Previous
Prevalence and incidence of Wegeners granulomatosis in the UK...

Next >>
Single-nucleotide polymorphisms p53G72C and Mdm2T309G in patients...